文献速递脊柱脊髓外科神经肿瘤

实体瘤转移性硬膜外脊髓压迫患者接受手术联合放疗的长期随访

Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy.
PubMed 文献 · World Neurosurg · 2018-04-27

该研究纳入2002至2009年间97例接受手术联合放疗的实体瘤硬膜外脊髓压迫患者,中位随访135个月,疼痛缓解率98%,神经功能恢复率51%,5年和10年局部控制率均为82.8%,中位总生存18个月,体能状态和椎体治疗时其他转移是生存影响因素(P < 0.01)。

要点

  • 手术联合放疗后疼痛缓解率98%,神经功能恢复率51%。
  • 5年和10年局部控制率均为82.8%,中位总生存18个月。
  • 体能状态和椎体治疗时其他转移是生存影响因素(P < 0.01)。

核心结论

  • 手术联合放疗是安全可行的治疗,并发症有限,在具有有利预后因素的选定患者中可能显著影响生存。

研究设计与样本

  • 纳入2002至2009年间97例接受手术联合放疗的实体瘤硬膜外脊髓压迫患者,中位随访135个月(范围96-209个月)。

主要发现

  • 姑息性减压占27%,肿瘤刮除(减瘤)占51%,全椎体切除占22%,术后78%接受放疗。
  • 疼痛缓解率98%,神经功能恢复率51%。
  • 5年和10年局部控制率均为82.8%。
  • 中位无进展生存12个月,5年和10年无进展生存率分别为16.9%和11.3%。
  • 中位总生存18个月,5年和10年总生存率分别为21.3%和12%。

关键数值与推荐

  • 放疗中位总剂量30 Gy,分10次。
  • 单因素和多因素分析显示,体能状态和椎体治疗时其他转移的存在是生存的影响因素(P < 0.01)。

临床怎么用

  • 手术联合放疗可用于体能状态好、转移局限、预期寿命超过3个月且有进行性神经功能缺损和/或难治性疼痛的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the outcome of patients with epidural spinal cord compression from different solid tumors treated with a combined approach, surgery plus radiotherapy (RT), with a follow-up longer than 10 years. METHODS: Ninety-seven patients treated between 2002 and 2009 were included. Surgical treatment was performed in patients with good performance status, limited metastatic disease, life expectancy longer than 3 months, and progressive neurologic deficit and/or intractable pain. RT was performed delivering a median total dose of 30 Gy in 10 fractions. Clinical outcome was evaluated using the modified visual analog scale for pain, the Frankel scale for neurologic deficit, and magnetic resonance imaging before treatment, after treatment, and every 3 months thereafter. RESULTS: Palliative decompression was performed in 27% of patients, tumor curettage (debulking) was performed in 51%, and total vertebrectomy was performed in 22%, followed by RT in 78% of cases. Pain remission was obtained in 98% of patients, and recovery of neurologic function was obtained in 51%. The median follow-up time was 135 months (range, 96-209 months). The 5- and 10-year local control rates were 82.8% and 82.8%, respectively. The median and 5- and 10-year progression-free survival rates were 12 months, 16.9%, and 11.3%, respectively; the median and 5- and 10-year overall survival rates were 18 months, 21.3%, and 12%, respectively. On univariate and multivariate analysis, factors recorded as conditioning survival were the performance status and the presence of other metastases at the time of vertebral treatment (P < 0.01). CONCLUSIONS: Our update confirmed that surgery plus RT is a safe and feasible treatment with limited morbidity. In selected patients with favorable prognostic factors, the combined treatment may significantly impact on survival.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pessina F, Navarria P, Carta GA, et al. Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy. World Neurosurg. 2018. PMID: 29709741. doi:10.1016/j.wneu.2018.04.136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。